Literature DB >> 17309103

Proteomic analysis of SET-binding proteins.

Jorge Vera1, Josep M Estanyol2, Nuria Canela2, Franc Llorens3, Neus Agell1, Emilio Itarte3, Oriol Bachs1, Montserrat Jaumot1.   

Abstract

The protein SET is involved in essential cell processes such as chromatin remodeling, apoptosis and cell cycle progression. It also plays a critical role in cell transformation and tumorogenesis. With the aim to study new SET functions we have developed a system to identify SET-binding proteins by combining affinity chromatography, MS, and functional studies. We prepared SET affinity chromatography columns by coupling the protein to activated Sepharose 4B. The proteins from mouse liver lysates that bind to the SET affinity columns were resolved with 2-DE and identified by MS using a MALDI-TOF. This experimental approach allowed the recognition of a number of SET-binding proteins which have been classified in functional clusters. The identification of four of these proteins (CK2, eIF2alpha, glycogen phosphorylase (GP), and TCP1-beta) was confirmed by Western blotting and their in vivo interactions with SET were demonstrated by immunoprecipitation. Functional experiments revealed that SET is a substrate of CK2 in vitro and that SET interacts with the active form of GP but not with its inactive form. These data confirm this proteomic approach as a useful tool for identifying new protein-protein interactions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17309103     DOI: 10.1002/pmic.200600458

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  9 in total

Review 1.  The Rac1 hypervariable region in targeting and signaling: a tail of many stories.

Authors:  B Daniel Lam; Peter L Hordijk
Journal:  Small GTPases       Date:  2013-01-25

2.  SET protein interacts with intracellular domains of the gonadotropin-releasing hormone receptor and differentially regulates receptor signaling to cAMP and calcium in gonadotrope cells.

Authors:  Charlotte Avet; Ghislaine Garrel; Chantal Denoyelle; Jean-Noël Laverrière; Raymond Counis; Joëlle Cohen-Tannoudji; Violaine Simon
Journal:  J Biol Chem       Date:  2012-12-11       Impact factor: 5.157

3.  Role of calcineurin, hnRNPA2 and Akt in mitochondrial respiratory stress-mediated transcription activation of nuclear gene targets.

Authors:  Manti Guha; Weigang Tang; Neal Sondheimer; Narayan G Avadhani
Journal:  Biochim Biophys Acta       Date:  2010-02-11

4.  Cell cycle and activation of CK2.

Authors:  Miwako Kato Homma; Yoshimi Homma
Journal:  Mol Cell Biochem       Date:  2008-07-23       Impact factor: 3.396

5.  Galectin-3 interacts with components of the nuclear ribonucleoprotein complex.

Authors:  Katharina Fritsch; Marco Mernberger; Andrea Nist; Thorsten Stiewe; Alexander Brehm; Ralf Jacob
Journal:  BMC Cancer       Date:  2016-07-19       Impact factor: 4.430

6.  GnRH regulates the expression of its receptor accessory protein SET in pituitary gonadotropes.

Authors:  Charlotte Avet; Chantal Denoyelle; David L'Hôte; Florence Petit; Céline J Guigon; Joëlle Cohen-Tannoudji; Violaine Simon
Journal:  PLoS One       Date:  2018-07-27       Impact factor: 3.240

7.  Cyclin-dependent kinase 1-mediated phosphorylation of SET at serine 7 is essential for its oncogenic activity.

Authors:  Ling Yin; Yongji Zeng; Yi Xiao; Yuanhong Chen; Hong Shen; Jixin Dong
Journal:  Cell Death Dis       Date:  2019-05-16       Impact factor: 8.469

8.  Phosphorylation of SET protein at Ser171 by protein kinase D2 diminishes its inhibitory effect on protein phosphatase 2A.

Authors:  Atsushi Irie; Kumiko Harada; Norie Araki; Yasuharu Nishimura
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

9.  Targeting of SET/I2PP2A oncoprotein inhibits Gli1 transcription revealing a new modulator of Hedgehog signaling.

Authors:  Iliana Serifi; Simoni Besta; Zoe Karetsou; Panagiota Giardoglou; Dimitris Beis; Pawel Niewiadomski; Thomais Papamarcaki
Journal:  Sci Rep       Date:  2021-07-06       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.